Press Releases Orthocell Limited

Equities

Market Closed - Australian S.E. Other stock markets 01:05:57 2024-05-14 EDT			5-day change	1st Jan Change
0.4 ^AUD	+2.56%		+6.67%	-2.44%

05-14	Orthocell's Striate+ Dental Membrane Product Achieves 98.6% Success Rate in Post-Market Clinical Study; Shares Up 3%	MT
04-15	Orthocell Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 3%	MT

Orthocell raising $3.5 million; adds heavy hitters to register	02-23	AQ
Orthocell on the cusp of significant growth	11-01	AQ
Orthocell thrilled to welcome John Van Der Wielen as chairman	23-05-29	AQ
Orthocell welcomes globally recognised nerve surgeons to advisory board	23-03-30	AQ
Orthocell welcomes high profile US-based healthcare specialist to the board	23-03-08	AQ
Orthocell : Notification regarding unquoted securities - OCC	22-04-21	PU
Orthocell : Application for quotation of securities - OCC	21-12-30	PU
Orthocell : Application for quotation of securities - OCC	21-12-23	PU
Orthocell : Application for quotation of securities - OCC	21-12-16	PU
Orthocell : OrthoATI Tendon Clinical Study Success	21-12-07	PU
Orthocell : Application for quotation of securities - OCC	21-11-18	PU
Application for quotation of securities - OCC	21-11-09	PU
Orthocell : Receives US Market Clearance	21-01-15	BU
Orthocell : Positive Pre-Clinical Results Using CelGro® in Anterior Cruciate Ligament (ACL) Reconstruction	18-02-04	BU
Orthocell : Secures New Patent for Suture-Less Repair of Soft Tissue	18-01-17	BU
Orthocell : Granted European Tendon Regeneration Patent	17-12-14	BU
Orthocell : Commences Treatment of Its 1,000th Patient	17-12-06	BU
Orthocell : Receives CE Mark for CelGro®	17-11-08	BU
Orthocell : Appoints Surgical Specialties as Exclusive Distributor	17-10-10	BU
Orthocell : 1st Patient Recruited in Orthocell Ortho-ATI® Shoulder Tendon Study	17-09-04	BU

No results for this search